期刊
TRENDS IN BIOCHEMICAL SCIENCES
卷 40, 期 7, 页码 377-384出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2015.03.002
关键词
CDG; disease; glycoprotein; endoplasmic reticulum; Golgi
资金
- Swiss National Foundation [310030-149949]
- Swiss National Science Foundation (SNF) [310030_149949] Funding Source: Swiss National Science Foundation (SNF)
Glycosylation is a ubiquitous modification of lipids and proteins. Despite the essential contribution of glycoconjugates to the viability of all living organisms, diseases of glycosylation in humans have only been identified over the past few decades. The recent development of next-generation DNA sequencing techniques has accelerated the pace of discovery of novel glycosylation defects. The description of multiple mutations across glycosylation pathways not only revealed tremendous diversity in functional impairments, but also pointed to phenotypic similarities, emphasizing the interconnected flow of substrates underlying glycan assembly. The current list of 100 known glycosylation disorders provides an overview of the significance of glycosylation in human development and physiology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据